Guide to Immunopeptidomics Profiling: LC-MS Applications in Antigen Discovery
- Ensuring high peptide recovery with strong specificity
- Minimizing interference from non-specific protein contaminants
- Maximally preserving low-abundance peptides
- Enabling peptide detection at the nanomolar level
- Accommodating the fragmentation behavior of short peptides (typically 8-14 amino acids) through optimized higher-energy collisional dissociation (HCD) settings
- Supporting combined strategies based on DDA (data-dependent acquisition) and DIA (data-independent acquisition) to increase coverage
- No-enzyme database searching
- Construction of customized databases incorporating fusion variants and translation products from non-coding regions, among other sequence sources
- Use of machine learning or deep learning tools (e.g., NetMHCpan and DeepLigand) to predict MHC-binding capacity
- Multi-omics integration, such as incorporating transcriptomic and mutanome-level information into the analysis workflow, to strengthen confidence in peptide identification
With the rapid expansion of tumor immunotherapy, personalized vaccine development, and autoimmune disease research, the bar for antigen discovery has risen substantially. In the era of precision medicine, investigators increasingly need to identify antigens that are genuinely visible to the immune system, targets that are not only relevant for therapeutic intervention, but also decisive for whether an immune response can be effectively initiated. Immunopeptidomics, a mass spectrometry-driven approach that directly profiles naturally presented peptides displayed by major histocompatibility complex (MHC) molecules, is increasingly regarded as a gold-standard strategy for interrogating antigen presentation. By purifying MHC complexes from cells or tissues and directly measuring their bound peptides using high-resolution mass spectrometry, immunopeptidomics provides a biologically grounded and comparatively comprehensive view of the antigenic landscape. In tumor neoantigen discovery in particular, this technology has already been applied to personalized vaccine development, CAR-T target validation, and investigations of immune-evasion mechanisms, highlighting its broad translational potential.
What Is Immunopeptidomics?
In higher organisms, MHC molecules are central to antigen presentation: proteins of endogenous or exogenous origin are processed into short peptides, which are ultimately displayed on the cell surface for T-cell recognition. MHC class I molecules primarily present peptides derived from cytosolic, endogenous proteins, whereas MHC class II pathways preferentially handle extracellular antigens. Immunopeptidomics directly reveals the protein fragments recognized by the immune system by eluting and identifying these naturally bound peptides from MHC molecules. This strategy can uncover concealed antigen classes, including mutant peptides, fusion-protein-derived peptides, and translation products originating from non-coding regions, thereby expanding the boundaries of immune target discovery.
The Core Role of Mass Spectrometry in Immunopeptidomics
1. Sample Preparation: Enrichment of Naturally Presented Peptides From MHC Molecules
The first step in immunopeptidomics is the selective enrichment of MHC molecules from cell lysates. In most workflows, MHC complexes are captured by co-immunoprecipitation using MHC-specific antibodies, and the associated peptides are subsequently eluted under mild conditions. The eluted peptides are then concentrated and desalted prior to LC-MS analysis.
The key considerations of this step are:
2. LC-MS/MS Analysis: High-Sensitivity Detection of Peptide Sequences
At the MS analysis stage, nanoflow liquid chromatography (nanoLC) coupled to high-resolution tandem mass spectrometry is commonly used for immunopeptide identification. Widely used platforms include Orbitrap Exploris instruments and the Q Exactive series. These systems offer several practical advantages:
3. Data Analysis: Addressing the Challenges of Non-Tryptic Peptides
Immunopeptides are not generated by enzymatic digestion and therefore lack fixed cleavage sites, which can reduce the effectiveness of conventional database-search strategies. To address this, researchers commonly apply the following approaches:
Technical Challenges and Future Trends
Challenge 1: Large Sample Requirement
Because MHC-bound peptides are typically present at extremely low abundance, immunopeptidomics often requires milligram-scale protein input or samples containing millions of cells, placing stringent demands on sample quality and the robustness of preparation workflows.
Challenge 2: High False-Positive Rate and Complex Data Analysis
Non-specific peptides and limitations in search algorithms can lead to false-positive annotations. As a result, stringent MS scoring thresholds and manual validation are often required to ensure high-confidence identifications.
Trend 1: Integrating DIA With AI Algorithms
Combining DIA workflows with deep learning-enabled spectral deconvolution is expected to substantially improve both the coverage and reproducibility of immunopeptide profiling.
Trend 2: Multi-Omics Integration to Improve the Efficiency of Neoantigen Discovery
Integrating mutational, transcriptomic, and epigenomic information may enable antigen-prioritization scoring frameworks, accelerating the screening and validation of candidate neoantigens.
By enabling biologically faithful, direct, and high-resolution antigen identification, immunopeptidomics is injecting new momentum into tumor immunotherapy, vaccine development, and autoimmune disease research. Mass spectrometry is the core engine powering this emerging field. From MHC enrichment to data interpretation, each step imposes stringent requirements on experimental platforms, MS sensitivity, and analytical algorithms. For researchers, a rigorous understanding of immunopeptidomics workflows and application boundaries can yield more precise answers to biological questions and lay a solid foundation for the next breakthrough discovery. MtoZ Biolabs is committed to translating advanced mass spectrometry technologies into implementable research solutions, supporting researchers in pushing the frontiers of immunology.
MtoZ Biolabs, an integrated chromatography and mass spectrometry (MS) services provider.
Related Services
How to order?
